hims & hers fda warning letter compounded semaglutide 2025 cancels plans to sell GLP-1 pill after backlash Hims & Hers Expands Personalized

First cardiovascular safety trial of a DPP-4 inhibitor in patients with T2DM and high cardiovascular risk, showing that saxagliptin does not augment MACE but increases hospitalization for heart failure

This unique mechanism of action sets retatrutide apart from traditional weight loss drugs such as semaglutide (Wegovy) as it aims to target all three of these key hormones involved in glucose (blood sugar levels) and satiety regulation

The emerging role of anti-hyperglycemic agents for the management of metabolic dysfunction-associated steatotic liver disease

Lab Work: Before starting Semaglutide, we require a set of lab tests to ensure the treatment is safe and appropriate for you

otherwise observation Breakthrough bleeding or spotting between periods: Likely mechanism: fluctuating estrogen levels during active weight loss Typical timeline: episodic during weeks 4 to 20 Associated findings: correlates with weeks of accelerated weight loss What it means: uterine lining is responding to unstable estrogen levels Management: usually benign